Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 294-436-0 | CAS number: 91722-33-7 A complex combination of organic compounds separated after condensation of the vapors from the destructive distillation of wood.
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 55.7 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 129 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 393 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Route to route extrapolation required for oral to inhalation route as no long term inhalation study available.
The dose starting point was the NOAEL result of 1129 mg/kg bw/day (female rats) obtained from the 90-day oral repeated dose toxicity study.
A modification of the dose descriptor starting point (oral to inhalation) was conducted. It is assumed as a worst case assumption that the oral absorption rate is 50% of that of the inhalation absorption.
The corrected dose descriptor (NOAEC) for inhalation was calculated in accordance with the ECHA Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterisation of dose [concentration]-response for human health.
The conversion of an oral rat NOAEL into a corrected inhalatory NOAEC to assess human inhalatory exposure was performed using the modification of starting point equation as given in Figure R. 8-3 (see below) for workers (in the case of 8 hour exposure/day).
Default parameters for rats and humans (for 8 hour exposure) were used for the modification of starting point under the allometric scaling principle as given in Table R. 8-2 of the above ECHA guidance.
An additional factor of 1.4 was included in the modification calculation to take into account correction for differences between human and experimental exposure conditions. When correcting an oral NOEAL to inhaltion NOEAC the correction factor for worker population would be : 7 day/week (experimental animal exposure) / 5 days/week (worker exposure conditions) = 1.4. This additional factor is also provided by the IUCLID DNEL calculator tool (for dose-dependent effects).
Conversion of an oral rate N(L)OAEL into a correct inhalatory N(L)OAEC to assess human inhalatory exposure:
For workers (in case of 8h exposure/day):
Corrected inhalatory N(L)OAEC = oral N(L)OAEL x (1 / sRVrat) x (ABSoral-rat / ABSinh-human) x (sRVhuman / wRV) x 1.4
Corrected inhalatory N(L)OAEC= 1129 mg/kg bw/day x (1 / 0.38 m3/kg/d) x (0.5) x (6.7 m3(8h) / 10 m3(8h)) x 1.4 = 1393 mg/m3
Where:
ABS: Absorption
sRV: standard Respiratory Volume
wRV: worker Respiratory Volume (light activity)
Default parametrs:
sRVrat (8 h): 0.38m3/kg bw
sRVhuman (8 h): 6.7 m3/ person
wRV (8 h): 10 m3/ person
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL an assessment factor of 1 is appropriate
- AF for differences in duration of exposure:
- 2
- Justification:
- Default AF for subchronic (90 day) to chronic studies
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- AF for allometric scaling not required as the differences in allometry (respiration rate and rat to human body sizes) were considered in the conversion from oral to inhalation starting point.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for remaining interspecies differences
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for worker population
- AF for the quality of the whole database:
- 1
- Justification:
- Relevant studies conducted to GLP and considered to be of reliability 1.
- AF for remaining uncertainties:
- 1
- Justification:
- None considered applicable.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 15.8 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 129 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 580.6 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Route to route extrapolation required for oral to dermal route as no long term dermal study available.
The dose starting point was the NOAEL result of 1129 mg/kg bw/day (female rats), obtained from the 90 day oral repeated dose toxicity study.
Modification of this oral result into a dermal starting point was performed.
It is considered that dermal absorption will not be higher than oral absorption, therefore no default factor (i.e. factor 1) should be introduced when performing oral-to dermal extrapolation.
An addition factor of 1.4 was included in the modification calculation to take into account correction for differences between human and experimental exposure conditions. When correcting an oral NOEAL to dermal NOEAL the correction factor for worker population would be : 7 day/week (experimental animal exposure) / 5 days/week (worker exposure conditions) = 1.4.
This additional factor is also provided by the IUCLID DNEL calculator tool (for dose-dependent effects).
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL an assessment factor of 1 is appropriate
- AF for differences in duration of exposure:
- 2
- Justification:
- Default AF for subchronic (90 day) to chronic studies
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default AF for allometric scaling based on rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for remaining interspecies differences
- AF for intraspecies differences:
- 5
- Justification:
- Default AF for worker population
- AF for the quality of the whole database:
- 1
- Justification:
- Relevant studies conducted to GLP and considered to be of reliability 1.
- AF for remaining uncertainties:
- 1
- Justification:
- None considered applicable.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.82 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 129 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 490.9 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Route to route extrapolation required for oral to inhalation route as no long term inhalation study available.
The dose starting point was the NOAEL result of 1129 mg/kg bw/day (female rats), obtained from the 90 day oral repeated dose toxicity study.
A modification of the dose descriptor starting point (oral to inhalation) was conducted. It is assumed as a worst case assumption that the oral absorption rate is 50% of that of the inhalation absorption.
The corrected dose descriptor (NOAEC) for inhalation was calculated in accordance with the ECHA Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterisation of dose [concentration]-response for human health.
Conversion of an oral rate N(L)OAEL into a correct inhalatory N(L)OAEC to assess human inhalatory exposure:
For general population (in case of 24 h exposure/day):
Corrected inhalatory N(L)OAEC = oral N(L)OAEL x (1 / sRVrat) x (ABSoral-rat / ABSinh-human)
Corrected inhalatory N(L)OAEC= 1129 mg/kg bw/day x (1 / 1.15 m3/kg/d) x (0.5) = 490.9 mg/m3
Where:
ABS: Absorption
sRV: standard Respiratory Volume
Default parametrs:
sRVrat (24 h): 1.15 m3/kg bw
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL an assessment factor of 1 is appropriate
- AF for differences in duration of exposure:
- 2
- Justification:
- Default AF for subchronic (90 day) to chronic studies
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- AF for allometric scaling not required as the differences in allometry (respiration rate and rat to human body sizes) were considered in the conversion from oral to inhalation starting point.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for remaining interspecies differences
- AF for intraspecies differences:
- 10
- Justification:
- Default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- None considered applicable.
- AF for remaining uncertainties:
- 1
- Justification:
- None considered applicable.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.65 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 129 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 129 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Route to route extrapolation required for oral to dermal route as no long term dermal study available.
The dose starting point was the NOAEL result of 1129 mg/kg bw/day (female rats) obtained from the 90 day oral repeated dose toxicity study.
Modification of this oral result into a dermal starting point was performed.
It is considered that dermal absorption will not be higher than oral absorption, therefore no default factor (i.e. factor 1) should be introduced when performing oral-to dermal extrapolation.
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL an assessment factor of 1 is appropriate
- AF for differences in duration of exposure:
- 2
- Justification:
- Default AF for subchronic (90 day) to chronic studies
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for rat
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for remaining interspecies differences
- AF for intraspecies differences:
- 10
- Justification:
- Default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- None considered applicable
- AF for remaining uncertainties:
- 1
- Justification:
- None considered applicable
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.65 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 129 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Not required as starting point is based on repeat dose oral study.
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL an assessment factor of 1 is appropriate
- AF for differences in duration of exposure:
- 2
- Justification:
- Default AF for subchronic (90 day) to chronic studies
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default AF for allometric scaling based on rats
- AF for other interspecies differences:
- 2.5
- Justification:
- Default AF for remaining interspecies differences
- AF for intraspecies differences:
- 10
- Justification:
- Default AF for general population
- AF for the quality of the whole database:
- 1
- Justification:
- Relevant studies conducted to GLP and considered to be of reliability 1.
- AF for remaining uncertainties:
- 1
- Justification:
- None considered applicable.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
